Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus (SLE) What is Systemic Lupus Erythematosus (SLE)? SLE is a chronic immune-mediated disease that can aect almost any organ system.1 Common Lupus Symptoms2,3,4 Headaches, confusion, memory loss Fatigue and fever Dry eyes Butterfly-shaped facial rash that covers cheeks and bridge of nose Chest pain, shortness of breath Photosensitivity (lesions on skin that appear/worsen when exposed to sunlight) Joint pain, stiness, swelling White or blue fingers or toes when cold or stressed (Raynaud's phenomenon) Prevalence OVER 90 PERCENT 20 PERCENT of SLE patients are of people with lupus young women around have a parent or sibling childbearing age.1 who already has lupus or may develop lupus.6 There are more than SLE is TWO TO FOUR 2.1 MILLION times more frequent, and patients worldwide with more severe, among moderate-to-severe lupus.5 nonwhite populations around the world.7 Disease Impact SLE has a significant impact on patients’ lives: • Disease flares can be unpredictable and many patients experience waxing and waning of symptoms.3 • Approximately up to 60 percent of SLE patients develop lupus nephritis (inflammation of the kidney).8 This represents a significant risk to morbidity and mortality as it can lead to kidney failure. Diagnosis & Treatment Signs and symptoms vary considerably from person to person and overlap with other diseases.3 There is a lack of reliable diagnosis markers,9 and no one test can diagnose lupus.3 Tests include:3 • Complete blood count and erythrocyte sedimentation rate • Liver and kidney assessments • Urine analysis • Antinuclear antibody test • X-rays and echocardiograms • Skin biopsy Treatment Limited treatment options exist for SLE. Bristol Myers Squibb is committed to identifying and pursuing new treatment options to help deliver transformational medicines for patients with systemic lupus erythematosus, lupus nephritis and other immune-mediated diseases. 1. Bartels, C.M. and Muller, D. “Systemic Lupus Erythematosus (SLE).” Medscape. http://emedicine.medscape.com/article/332244-overview. Accessed October 25, 2020. 2. Piedmont Healthcare. “What is Lupus.” http://www.piedmont.org/living-better/what-is-lupus Accessed October 25, 2020. 3. Mayo Clinic. "Lupus." https://www.mayoclinic.org/diseases-conditions/lupus/symptoms-causes/syc-20365789. Accessed October 25, 2020. 4. Mayo Clinic. “Raynaud's disease.” https://www.mayoclinic.org/diseases-conditions/raynauds-disease/symptoms-causes/syc-20363571. Accessed April 28, 2021. 5. BMS Epidemiology Data on File. 6. Lupus Foundation of America. “Statistics on Lupus.” http://www.lupus.org/about/statistics-on-lupus. Accessed October 25, 2020. 7. Pons-Estel, G. et al. Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus. Semin Arthritis Rheum. 2010 Feb; 39(4): 257. 8. Lupus Foundation of America. "How Lupus Affects the Renal (Kidney) System." https://www.lupus.org/resources/how-lupus-affects-the-renal-kidney-system. Accessed October 25, 2020. 9. Liu, C. et al. Biomarkers in systemic lupus erythematosus: challenges and prospects for the future. Ther Adv Musculoskelet Dis. 2013 Aug; 5(4): 210–233..

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    1 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us